135 related articles for article (PubMed ID: 394837)
1. Dibromodulcitol.
Mischler NE; Earhart RH; Carr B; Tormey DC
Cancer Treat Rev; 1979 Sep; 6(3):191-204. PubMed ID: 394837
[No Abstract] [Full Text] [Related]
2. Phase I and II studies of cytostatic hexitol derivatives: the role of alkylating metabolites?
Eckhardt S; Kerpel-Fronius S; Horváth IP; Institoris L
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 2):783-8. PubMed ID: 3985644
[No Abstract] [Full Text] [Related]
3. Positive phase II trial of dibromodulcitol in patients with metastatic melanoma refractory to DTIC and a nitrosourea.
Bellet RE; Catalano RB; Mastrangelo MJ; Berd D
Cancer Treat Rep; 1978 Dec; 62(12):2095-9. PubMed ID: 751717
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of dibromodulcitol (NSC-104800).
Andrews NC; Weiss AJ; Wilson W; Nealon T
Cancer Chemother Rep; 1974; 58(5 Pt 1):653-60. PubMed ID: 4426045
[No Abstract] [Full Text] [Related]
5. Observations on dibromodulcitol (DBD)-mitolactol-treatment.
Perényl G; Büttner K; Dénes L
Ther Hung; 1977; 25(1):16-9. PubMed ID: 854865
[No Abstract] [Full Text] [Related]
6. The binding of in vivo administered dibromodulcitol to the DNA, histone and non-histone of Yoshida ascites tumor cells.
Institóris E; Holczinger L; Bánfi D
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1974; 82(2):101-7. PubMed ID: 4278499
[No Abstract] [Full Text] [Related]
7. A phase II evaluation of mitolactol in patients with advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
Stehman FB; Blessing JA; McGehee R; Barrett RJ
J Clin Oncol; 1989 Dec; 7(12):1892-5. PubMed ID: 2685182
[TBL] [Abstract][Full Text] [Related]
8. [New cytostatics in oncological therapy].
Osieka R; Seeber S; Bruntsch U; Gallmeier WM; Schmidt CG
Dtsch Med Wochenschr; 1974 Nov; 99(48):2468-74. PubMed ID: 4141307
[No Abstract] [Full Text] [Related]
9. Phase I--II study of hexamethylmelamine plus dibromodulcitol in refractory carcinoma of the breast.
Van Amburg AL; Presant CA; Vélez-García E; Klahr C
Cancer Treat Rep; 1979 Jan; 63(1):141-2. PubMed ID: 105806
[No Abstract] [Full Text] [Related]
10. Clinical trials with the hexitol derivatives in the U.S.
Chiuten DF; Rozencweig M; Von Hoff DD; Muggia FM
Cancer; 1981 Feb; 47(3):442-51. PubMed ID: 6784907
[TBL] [Abstract][Full Text] [Related]
11. [Value of mitolactol in palliative treatment of various malignant tumors].
Wiernik-Strzeszyńska E; Pawlicki M
Nowotwory; 1980; 30(3):271-6. PubMed ID: 6159601
[No Abstract] [Full Text] [Related]
12. A phase III study in lung carcinoma comparing hexamethyl-melamine (NSC 13875) to dibromodulcitol (NSC 104800) 1,2.
Wilson WL; Ryzin JV; Weiss AJ; Frelick RW; Moss SE
Oncology; 1975; 31(5-6):293-309. PubMed ID: 174041
[TBL] [Abstract][Full Text] [Related]
13. [Therapeutic effectiveness of carminomycin (CRM) in combination with dibromodulcitol (DBD) compared with the combination vincristine, cyclophosphamide, methotrexate, 5-fluorouracil (VCMF) on some tumor systems (author's transl)].
Nowak C; Arnold W; Henneberger G; Tanneberger S
Arch Geschwulstforsch; 1980; 50(8):747-57. PubMed ID: 7224818
[TBL] [Abstract][Full Text] [Related]
14. Effect of Mitolactol (Dibromodulcitol) treatment in bladder cancer.
Vecsey D
Ther Hung; 1978; 26(2):67-72. PubMed ID: 684658
[No Abstract] [Full Text] [Related]
15. Pilot studies of various combinations of dibromodulcitol, VP-16, and AMSA.
Eagan RT
Oncology; 1982; 39(5):295-7. PubMed ID: 6896559
[TBL] [Abstract][Full Text] [Related]
16. The effect of dibromodulcitol (Elobromolr, Mitolactolr, nsc 104 800) on the postoperative recurrences of the Guerin carcinoma of the rat.
Németh L; Somfai S
Neoplasma; 1976; 23(1):37-41. PubMed ID: 1272472
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapeutic approaches to brain tumors. Experimental observations with dianhydrogalactitol and dibromodulcitol.
Levin VA; Wheeler KT
Cancer Chemother Pharmacol; 1982; 8(1):125-31. PubMed ID: 7094198
[TBL] [Abstract][Full Text] [Related]
18. Dibromodulcitol in the treatment of metastatic hemangiopericytoma.
Conroy JF; Roda PI; Prasasvinichai S
Am J Clin Oncol; 1982 Aug; 5(4):453-6. PubMed ID: 7113966
[TBL] [Abstract][Full Text] [Related]
19. Dibromodulcitol (NSC-104800) compared with cyclophosphamide (NSC-26271) as remission maintenance therapy in previously treated children with acute lymphoblastic leukemia or acute undifferentiated leukemia: possible effectiveness in reducing the incidence of central nervous system leukemia.
Sitarz AL; Albo V; Movassaghi N; Karon M; Hammond D; Weiner J; Reed A
Cancer Chemother Rep; 1975; 59(5):989-94. PubMed ID: 1106848
[TBL] [Abstract][Full Text] [Related]
20. Dibromodulcitol in the treatment of breast cancer.
Falkson G; Pretorius L; Falkson HC
Cancer Treat Rev; 1982 Dec; 9(4):261-6. PubMed ID: 6762921
[No Abstract] [Full Text] [Related]
[Next] [New Search]
